Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Brivaracetam
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Brivaracetam 100mg tablets
0408010ALAAAEAE
|
Brivaracetam | Brivaracetam | Central Nervous System | 13,223 |
|
Brivaracetam 50mg tablets
0408010ALAAACAC
|
Brivaracetam | Brivaracetam | Central Nervous System | 9,350 |
|
Brivaracetam 25mg tablets
0408010ALAAABAB
|
Brivaracetam | Brivaracetam | Central Nervous System | 5,555 |
|
Brivaracetam 75mg tablets
0408010ALAAADAD
|
Brivaracetam | Brivaracetam | Central Nervous System | 3,734 |
|
Brivaracetam 50mg/5ml oral solution sugar free
0408010ALAAAGAG
|
Brivaracetam | Brivaracetam | Central Nervous System | 2,691 |
|
Brivaracetam 10mg tablets
0408010ALAAAAAA
|
Brivaracetam | Brivaracetam | Central Nervous System | 670 |
|
Brivaracetam 50mg/5ml solution for injection vials
0408010ALAAAFAF
|
Brivaracetam | Brivaracetam | Central Nervous System | 2 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.